What has changed in the world of Decentralized Clinical Trials since the pandemic?
Sponsored by: Parexel
- Decentralized Clinical Trials
Date: 26 May
Time: 2PM London/3PM CET
A spotlight on direct to and from patient shipments
We all know that the adoption of Decentralized Clinical Trials (DCTs) has accelerated during the pandemic. Much has changed – some elements have rapidly evolved and others have continued as before. So, what do you need to know to successfully operationalize Direct-to-Patient (DTP) shipments in this DCT world?
Today, we’ll share lessons learned and bust some myths to make your job easier. This webinar will cover DTP aspects of DCTs with a focus on patient, physician, and regulatory compliance needs including touching on how the supplies required can dictate the complexity of the DTP approach.
What you’ll learn:
• Lessons learned from patients and physicians related to DTPs and other key DCT methods.
• A variety of DTP strategies depending on the regulatory environment of the region.
• Successful case studies pertaining to DTPs.
Call to action:
There is no one-size-fits all approach to DTPs. Your flexibility and timely adoption is key to successfully supporting patients and meeting regulatory requirements.
Vice President, Patient Innovation Center
Roz leads Parexel’s Patient Innovation Center, focused on improving research access and experiences for patients and caregivers. This includes leadership of the decentralized clinical trials service, activities to improve diversity in clinical research, and creation of other tools and services that reduce practical, financial and geographical barriers to participation. She has 17 years of leadership experience in patient engagement and innovation roles, and regularly presents and authors articles on the topic.
Director, Solutions Consulting - Clinical Trial Supplies ＆ Logistics
Laurie has been with PAREXEL since 2012, and held positions in clinical supply project management and account management. Prior to joining PAREXEL Laurie’s primary focus was project management of the full drug supply lifecycle from forecasting and planning through returns and destruction. She has experience managing a variety of projects and products including: large global development programs, temperature sensitive biologics, controlled substances and cell and gene therapy. Laurie has worked in the clinical trial industry for almost 20 years. She is an experienced clinical supply professional with 15+ years of global clinical supply chain project management experience. She has a B.S in Biochemistry and an MA in Kinesiology from the University of Texas.